FDA inspection
California Stem Cell Treatment Center, Inc: FDA inspection ending Jul 27, 2017
FDA inspection 1019395 · Official Action Indicated (OAI) · Beverly Hills, CA
Key facts
| Inspection ID | 1019395 |
|---|---|
| Firm | California Stem Cell Treatment Center, Inc |
| FEI number | 3013670025 |
| Address | 120 S Spalding Dr Ste 300 |
| City | Beverly Hills |
| State | CA |
| ZIP | 90212 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Jul 27, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data